Recognising the roles of rare diseases stakeholders, the
World Orphan Drug Congress Asia 2017
patient groups, government and experts to join the discussion on providing proper medical care
for rare disease patient care in the Asia Pacific region.
What can patient groups do to help ease challenges in orphan drug access? Understand industry perspective and collaborate to resolve challenges fast.
Why not subsidize orphan drugs? Share your perspective; be understood and work toward a solution.
How can you start to define rare disease? Leverage how others have defined rare disease and provide a pathway for orphan drugs to your rare disease patients.
Pharma, biopharma & biotech
Understand Asia’s market access culture and infrastructure. See how best to provide orphan drugs to rare disease patients in the region.